InvestorsHub Logo
Followers 4
Posts 326
Boards Moderated 0
Alias Born 10/19/2005

Re: SpecTrader post# 24183

Thursday, 12/20/2012 1:00:13 PM

Thursday, December 20, 2012 1:00:13 PM

Post# of 130505
Think bigger. I believe this gets to a $100 Million market cap at least. Ask yourself two simple questions:

(1) Why is the co-founder of Amgen wasting his time on this board, presenting on the commercial opportunities of MANF at some biotech conference and saying MANF "could be one of the biggest successes that I have ever seen" and that "MANF has the commercial potential to become a blockbuster drug."?

(2) Why is another biotech startup working in the same field also with Michael J. Fox Foundation grants challenging their patents? http://seekingalpha.com/instablog/167303-jonathan-verenger/1348791-exciting-field-in-cure-for-parkinson-s

The fact that this company has a $13 Million market cap is a joke. This is being accumulated as we speak. I'm not wasting time listening to some college kids with $3,000 to their name post on this board trying to spread fear. Instead I'm going to listen to the founder of Amgen, the senior execs at Bayer and Bristol Myers and the prior president of the American Medical Association Foundation, all of whom are on this company's board. All of them believe in MANF and MANF has shown much better results than GDNF at this stage of testing, which is when it was purchased for $250 Million.

Give it a few weeks/months and we will be sitting here with a $25 Million partnership deal with additional milestones in place for more funding. Where do you think the stock will be then? I'm gonna go with higher than $0.12. Again, anyone selling now will regret this a lot. Oh and by the way it doesn't matter if they get another grant from MJFF. We're all here for the big partnership from a big pharma company. It's coming.